ISSN 1016-5169 | E-ISSN 1308-4488
Digital Technologies in Heart Failure Management [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2024; 52(1): 52-60 | DOI: 10.5543/tkda.2023.79776

Digital Technologies in Heart Failure Management

Evrim Şimşek1, Yetkin Korkmaz2, Serdar Bozyel3, Arda Güler4, Duygu Koçyiğit Burunkaya5, Mehmet Ertürk4, Nurgül Keser2
1Department of Cardiology, Ege University Faculty of Medicine, Izmir, Türkiye
2Department of Cardiology, University of Health Sciences, Sultan Abdülhamid Han Training and Research Hospital, Istanbul, Türkiye
3Department of Cardiology, Derince Training and Research Hospital, Kocaeli, Türkiye
4University of Health Sciences, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, İstanbul, Türkiye
5Cardiology Clinic, Ankara Bilkent City Hospital, Ankara, Türkiye

Heart Failure (HF) is an important public health problem in Turkey and in the world. Hospitalizations due to HF decompensation are associated with increased mortality. The use of digital technologies, especially wearable technologies, is increasing. As physicians, with the use of these devices, patients could be closely followed up and hospitalization, mortality are tried to be prevented by increased awareness of decomposition before clinical symptoms or at the beginning of symptoms. In this review, digital biomarkers, digital technologies, remote monitoring systems and the evidence supporting their use, artificial intelligence applications and the reasons limiting their use of digital technologies in clinical practice will be discussed.

Keywords: Artificial intelligence, digital health and telemedicine, heart failure

Corresponding Author: Evrim Şimşek, Türkiye
Manuscript Language: English
×
APA
NLM
AMA
MLA
Chicago
Copied!
CITE


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search

Copyright © 2024 Archives of the Turkish Society of Cardiology



Kare Publishing is a subsidiary of Kare Media.